Copart
CPRT
26.62
-0.20
-0.75%
Copart
US · CPRT
#782 by market cap
Listed 1970
26.62
-0.20
-0.75%
Live - 5344 symbols - heartbeat 475s ago
· 2026-10-08 08:24
Pre-market
26.68
+0.23%
After-hours
26.65
+0.11%
Overnight
26.56
-0.23%
- Market cap
- 24.66B
- P/E (TTM)i
- 17.17
- P/Bi
- 2.71
- EPSi
- 1.55
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on CPRT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 18.89, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.41% YoY
Margins
- Gross margin
- 44.66%
- Operating margin
- 35.42%
- Net margin
- 31.81%
Key ratios & quality
- PEG ratioi
- 2.75
- Altman Z-Scorei
- 18.89
PEG uses trailing P/E against the 3-year net income growth rate (6.24%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.04B | 2.21B | 2.69B | 3.50B | 3.87B | 4.24B | 4.65B | 4.67B |
| Gross profit | 898.34M | 1.01B | 1.34B | 1.61B | 1.74B | 1.91B | 2.10B | 2.08B |
| Selling & admin expenses | 181.87M | 191.70M | 206.67M | 231.22M | 250.42M | 335.23M | 402.93M | 431.27M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 716.48M | 816.10M | 1.14B | 1.37B | 1.49B | 1.57B | 1.70B | 1.65B |
| Pretax profit | 704.95M | 800.84M | 1.12B | 1.34B | 1.55B | 1.71B | 1.90B | 1.83B |
| Tax | 113.26M | 100.93M | 185.35M | 250.82M | 316.59M | 352.25M | 347.22M | 354.58M |
| Net profit | 591.69M | 699.91M | 936.50M | 1.09B | 1.24B | 1.36B | 1.55B | 1.48B |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Diluted EPS | 0.62 | 0.73 | 0.97 | 1.13 | 1.28 | 1.40 | 1.59 | 1.55 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 1.21B | 1.13B | 1.16B | 1.12B | 1.24B | 1.15B |
| Gross profit | 552.27M | 509.72M | 537.00M | 492.81M | 572.60M | 481.45M |
| Selling & admin expenses | 100.72M | 97.13M | 106.30M | 104.10M | 108.32M | 112.55M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 451.55M | 412.59M | 430.69M | 388.71M | 464.28M | 368.90M |
| Pretax profit | 502.80M | 478.41M | 487.12M | 441.05M | 502.09M | 404.71M |
| Tax | 97.47M | 83.10M | 84.91M | 91.08M | 100.70M | 77.88M |
| Net profit | 405.34M | 395.31M | 402.21M | 349.97M | 401.39M | 326.83M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.42 | 0.41 | 0.41 | 0.36 | 0.43 | 0.35 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 687.17M | 963.76M | 1.70B | 2.20B | 3.26B | 4.42B | 5.75B | 5.57B |
| Cash & ST investments | 186.32M | 477.72M | 1.05B | 1.38B | 2.36B | 3.42B | 4.79B | 4.49B |
| Inventory | 20.94M | 20.08M | 44.97M | 58.79M | 39.97M | 43.64M | 39.66M | 51.38M |
| Total assets | 2.55B | 3.46B | 4.56B | 5.31B | 6.74B | 8.43B | 10.09B | 10.03B |
| Total current liabilities | 282.00M | 356.04M | 421.03M | 440.89M | 492.77M | 628.57M | 683.28M | 703.74M |
| Short-term debt | 1.14M | 25.57M | 22.47M | 21.79M | 21.47M | 21.30M | 19.87M | 15.16M |
| Long-term debt | 400.09M | 396.90M | 397.64M | 2.00M | 10.90M | -- | -- | -- |
| Total liabilities | 769,236,000.00 | 965,745,000.00 | 1,032,942,000.00 | 683,265,000.00 | 750,439,000.00 | 879,209,000.00 | 883,411,000.00 | 913,930,000.00 |
| Total equity | 1.78B | 2.49B | 3.53B | 4.63B | 5.99B | 7.55B | 9.21B | 9.11B |
| Retained earnings | 1.34B | 1.94B | 2.87B | 3.96B | 5.19B | 6.55B | 8.09B | 7.98B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 5.36B | 5.75B | 6.20B | 6.18B | 5.22B | 5.57B |
| Cash & ST investments | 4.38B | 4.79B | 5.24B | 5.10B | 4.20B | 4.49B |
| Inventory | 44.51M | 39.66M | 40.41M | 41.87M | 49.63M | 51.38M |
| Total assets | 9.67B | 10.09B | 10.58B | 10.59B | 9.65B | 10.03B |
| Total current liabilities | 657.13M | 683.28M | 781.20M | 613.87M | 685.26M | 703.74M |
| Short-term debt | 19.79M | 19.87M | 17.87M | 16.69M | 15.83M | 15.16M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 869,525,000.00 | 883,411,000.00 | 961,903,000.00 | 787,728,000.00 | 857,591,000.00 | 913,930,000.00 |
| Total equity | 8.80B | 9.21B | 9.62B | 9.81B | 8.79B | 9.11B |
| Retained earnings | 7.70B | 8.09B | 8.50B | 8.63B | 7.65B | 7.98B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 646.65M | 917.89M | 990.89M | 1.18B | 1.36B | 1.47B | 1.80B | 1.60B |
| Depreciation & amortization | 85.33M | 104.26M | 123.08M | 138.61M | 159.68M | 190.26M | 217.78M | 238.47M |
| Free cash flow | 272.76M | 325.91M | 527.90M | 839.24M | 847.57M | 961.57M | 1.23B | 1.27B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -365.00M | -- | -- | -- | -- | 0 | 0 | -1.63B |
| Ending cash balance | 186.32M | 477.72M | 1.05B | 1.38B | 957.40M | 1.51B | 2.78B | 1.91B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 700.87M | 438.48M | 535.25M | 127.50M | 584.20M | 357.54M |
| Depreciation & amortization | 54.52M | 54.14M | 54.20M | 55.51M | 59.09M | 69.67M |
| Free cash flow | 572.92M | 350.84M | 427.21M | 57.88M | 503.31M | 278.73M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -1.41B | -1.00K |
| Ending cash balance | 2.37B | 2.78B | 5.23B | 5.10B | 3.35B | 1.91B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 35.23 | 32.80 | 31.12 | 26.74 | 23.32 | 20.18 | 18.58 | 16.24 |
| ROA %i | 24.37 | 23.32 | 23.36 | 22.09 | 20.55 | 17.98 | 16.77 | 14.76 |
| ROIC %i | 29.15 | 27.62 | 27.03 | 25.11 | 22.81 | 19.82 | 18.34 | 16.07 |
| 5-year avg ROE %i | 32.39 | 34.48 | 34.49 | 31.41 | 29.84 | 26.83 | 23.99 | 21.01 |
| EBIT margin %i | 35.49 | 37.23 | 42.42 | 38.78 | 38.42 | 37.10 | 36.51 | 35.42 |
| FCF / sales %i | 13.36 | 14.78 | 19.61 | 23.97 | 21.90 | 22.70 | 26.49 | 27.16 |
| Current ratioi | 2.44 | 2.71 | 4.04 | 5.00 | 6.62 | 7.03 | 8.42 | 7.91 |
| Quick ratioi | 2.03 | 2.40 | 3.68 | 4.57 | 6.24 | 6.69 | 8.13 | 7.60 |
| Debt / assetsi | 15.75 | 15.01 | 11.36 | 2.25 | 1.79 | 1.41 | 1.03 | 0.88 |
| LT debt / equityi | 22.50 | 19.81 | 14.04 | 2.11 | 1.65 | 1.29 | 0.91 | 0.80 |
| Interest coveragei | 36.59 | 40.59 | 56.41 | 81.35 | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 17.20 | 15.06 | 14.25 | 19.69 | 20.61 | 16.31 | 9.90 | 6.44 |
| Net income CAGR (3Y) %i | 29.83 | 21.09 | 30.86 | 22.59 | 20.93 | 13.33 | 12.51 | 6.24 |
| FCF CAGR (3Y) %i | 19.82 | 0.62 | 28.78 | 45.45 | 37.52 | 22.13 | 13.61 | 14.34 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 18.54 | 18.58 | 18.22 | 17.22 | 17.69 | 16.24 |
| ROA %i | 16.72 | 16.77 | 16.39 | 15.75 | 16.08 | 14.76 |
| ROIC %i | 18.29 | 18.34 | 18.00 | 17.02 | 17.50 | 16.07 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 35.80 | 36.51 | 36.97 | 36.49 | 36.57 | 35.42 |
| FCF / sales %i | 25.73 | 26.49 | 30.34 | 30.54 | 28.87 | 27.16 |
| Current ratioi | 8.16 | 8.42 | 7.94 | 10.06 | 7.61 | 7.91 |
| Quick ratioi | 7.83 | 8.13 | 7.69 | 9.72 | 7.29 | 7.60 |
| Debt / assetsi | 1.04 | 1.03 | 0.94 | 0.91 | 0.97 | 0.88 |
| LT debt / equityi | 0.93 | 0.91 | 0.85 | 0.81 | 0.88 | 0.80 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
United States81.60%
International18.40%
Quote time 2026-10-08 08:24:13 · For reference only, not investment advice and not tailored to your situation.